Download PDF

The effect of cholesterol-lowering therapy on the progression of diabetic nephropathy is unproved

Diabetologia volume 39, pages368–370(1996)Cite this article

An Erratum to this article was published on 01 August 1996

References

  1. 1.

    Lam KSL, Cheng IKP, Janus ED, Pang RWC (1995) Cholesterol-lowering therapy may retard the progression of diabetic nephropathy. Diabetologia 38: 604–609

    Google Scholar 

  2. 2.

    Andersen B (1990) Methodological errors in medical research. Blackwell, Oxford London Edinburgh Boston Melbourne Paris Berlin Vienna

    Google Scholar 

  3. 3.

    Crowder MJ, Hand DJ (1990) Analysis of repeated measures. Chapman and Hall, London New York Tokyo Melbourne Madras

    Google Scholar 

  4. 4.

    Senn S (1994) Testing for baseline balance in clinical trials. Stat Med 13: 1715–1726

    Google Scholar 

  5. 5.

    Matthews JNS, Altman DG, Campbell MJ, Royston P (1990) Analysis of serial measurements in medical research. BMJ 300: 230–235

    Google Scholar 

References

  1. 1a.

    Lam KSL, Cheng IKP, Janus ED, Pang RWC (1995) Cholesterol-lowering therapy may retard the progression of diabetic nephropathy. Diabetologia 38: 604–609

    Google Scholar 

Download references

Author information

Affiliations

  1. Department of Metabolic Diseases and Nutrition, Heinrich-Heine-Universität Düsseldorf, P.O. Box 101007, D-40001, Düsseldorf, Germany

    Dr. R. Bender

  2. Departments of Medicine, The University of Hong Kong, Hong Kong

    Dr. K. S. L. Lam & Dr. I. J. Lauder

Authors
  1. Dr. R. Bender
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dr. K. S. L. Lam
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Dr. I. J. Lauder
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Dr. R. Bender or Dr. K. S. L. Lam or Dr. I. J. Lauder.

Additional information

An erratum to this article is available at http://dx.doi.org/10.1007/BF00403925.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Bender, R., Lam, K.S.L. & Lauder, I.J. The effect of cholesterol-lowering therapy on the progression of diabetic nephropathy is unproved. Diabetologia 39, 368–370 (1996). https://doi.org/10.1007/BF00418357

Download citation

Keywords

  • Public Health
  • Internal Medicine
  • Human Physiology
  • Metabolic Disease
  • Diabetic Nephropathy